1. Biology Dictates Prognosis Following Resection of Gallbladder Carcinoma: Sometimes Less is More

   • Timothy M. Pawlik
   • Michael A. Choti

   Hepatobiliary and Pancreatic Tumors Open access 23 January 2009 Pages: 787 - 788

2. Pancreaticoduodenectomy and Vascular Resection: Persistent Controversy and Current Recommendations

   • Kathleen Christians
   • Douglas B. Evans

   Hepatobiliary and Pancreatic Tumors Open access 24 January 2009 Pages: 789 - 791

3. Differentiating Early and Late Recurrences After Resection of HCC in Cirrhotic Patients: Implications on Surveillance, Prevention, and Treatment Strategies

   • Ronnie T. P. Poon

   Hepatobiliary and Pancreatic Tumors Open access 04 February 2009 Pages: 792 - 794

4. Genome-Wide Association Studies and Aggressive Surgery Toward Individualized Prevention, and Improved Local Control and Overall Survival for Gastric Cancer

   • Dimitrios H. Roukos

   Gastrointestinal Oncology 24 January 2009 Pages: 795 - 798

5. Nanoneoadjuvant Therapy of Gastrointestinal Stromal Tumor (GIST)

   • Ronald P. DeMatteo

   Bone and Soft Tissue Sarcomas Open access 24 January 2009 Pages: 799 - 800

6. BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management

   • Mingzhao Xing

   Endocrine Tumors Open access 22 January 2009 Pages: 801 - 803

7. Follow-Up of Melanoma Patients: The Need for Evidence-Based Protocols

   • Anne Brecht Francken
   • Harald J. Hoekstra

   Melanomas Open access 03 February 2009 Pages: 804 - 805

8. Analysis of the Extent of Resection for Adenocarcinoma of the Gallbladder

   • Michael D’Angelica
   • Kimberly Moore Dalal
   • William R. Jarnagin

   Hepatobiliary and Pancreatic Tumors 05 November 2008 Pages: 806 - 816

   

9. Does Portal-Superior Mesenteric Vein Invasion Still Indicate Irresectability for Pancreatic Carcinoma?

   • Giovanni Ramacciato
   • Paolo Mercantini
   • Massimo Del Gaudio

   Hepatobiliary and Pancreatic Tumors 21 January 2009 Pages: 817 - 825

10. Low-Level Expression of Smad7 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Pancreatic Cancer

    • Peng Wang
    • Jie Fan
    • Lu-Ming Liu

    Hepatobiliary and Pancreatic Tumors 23 January 2009 Pages: 826 - 835

    

11. Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    • Matthew H. G. Katz
    • Huamin Wang
    • Douglas B. Evans

    Hepatobiliary and Pancreatic Tumors Open access 05 February 2009 Pages: 836 - 847

    

12. Liver Resection Improves the Survival of Patients with Multiple Hepatocellular Carcinomas

    • Ming-Chih Ho
    • Guan-Tarn Huang
    • Chien-Hung Chen

    Hepatobiliary and Pancreatic Tumors 22 January 2009 Pages: 848 - 855

    

13. Bevacizumab-Related Surgical Site Complication Despite Primary Tumor Resection in Colorectal Cancer Patients

    • Thierry Bège
    • Bernard Lelong
    • Jean Robert Delpero

    Gastrointestinal Oncology 21 January 2009 Pages: 856 - 860

    

14. Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer

    • In Kyu Lee
    • Do Hyoung Kim
    • Seong Taek Oh

    Gastrointestinal Oncology 03 February 2009 Pages: 861 - 870

    

15. APC, MYH, and the Correlation Genotype-Phenotype in Colorectal Polyposis

    • Jérémie H. Lefevre
    • Yann Parc
    • Emmanuel Tiret

    Gastrointestinal Oncology 24 January 2009 Pages: 871 - 877

    

16. Response to Preoperative Therapy in Upper Gastrointestinal Cancers

    • Björn L. D. M. Brücher
    • Stephen G. Swisher
    • Jaffer A. Ajani

    Gastrointestinal Oncology 05 February 2009 Pages: 878 - 886

17. Infralevator Lymphatic Drainage of Low-Rectal Cancers: Preliminary Results

    • Marek Bębenek
    • Andrzej Wojnar

    Gastrointestinal Oncology 23 January 2009 Pages: 887 - 892

    

18. Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherapy for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months

    • Salvatore Pucciarelli
    • Giuseppe Gagliardi
    • Donato Nitti

    Gastrointestinal Oncology 03 February 2009 Pages: 893 - 899

    

19. Operative Safety and Oncologic Outcomes of Anal Sphincter-Preserving Surgery with Mesorectal Excision for Rectal Cancer: 931 Consecutive Patients Treated at a Single Institution

    • Nam-Kyu Kim
    • Young-Wan Kim
    • Chang-Hwan Cho

    Gastrointestinal Oncology 07 February 2009 Pages: 900 - 909

    

20. A Randomized, Phase II Study of Preoperative plus Postoperative Imatinib in GIST: Evidence of Rapid Radiographic Response and Temporal Induction of Tumor Cell Apoptosis

    • John C. McAuliffe
    • Kelly K. Hunt
    • Jonathan C. Trent

    Bone and Soft Tissue Sarcomas Open access 25 October 2008 Pages: 910 - 919

    

21. Extent of Thyroidectomy and Lymphadenectomy in 254 Patients With Papillary Thyroid Microcarcinoma: A Single-Institution Experience

    • Nikola Besic
    • Janez Zgajnar
    • Rok Petric

    Endocrine Tumors 03 February 2009 Pages: 920 - 928

22. The Cost-Effectiveness of Sentinel Node Biopsy in Patients with Intermediate Thickness Primary Cutaneous Melanoma

    • R. L. Morton
    • K. Howard
    • J. F. Thompson

    Melanomas 30 September 2008 Pages: 929 - 940

    

23. Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging

    • Michael O. Meyers
    • Jen Jen Yeh
    • David W. Ollila

    Melanomas 20 December 2008 Pages: 941 - 947

    

24. An Increased Number of Sentinel Lymph Nodes Is Associated with Advanced Breslow Depth and Lymphovascular Invasion in Patients with Primary Melanoma

    • Carl R. Schmidt
    • Katherine S. Panageas
    • Mary S. Brady

    Melanoma 05 February 2009 Pages: 948 - 952

    

25. Optimizing Melphalan Pharmacokinetics in Regional Melanoma Therapy: Does Correcting for Ideal Body Weight Alter Regional Response or Toxicity?

    • N. McMahon
    • T. Y. Cheng
    • Douglas S. Tyler

    Melanomas 30 January 2009 Pages: 953 - 961

    

26. Endogenous NIS Expression in Triple-Negative Breast Cancers

    • Corinne Renier
    • Chen Yao
    • Irene Wapnir

    Breast Oncology 28 January 2009 Pages: 962 - 968

    

27. Circulating Tumor Cells in Patients Undergoing Surgery for Primary Breast Cancer: Preliminary Results of a Pilot Study

    • Brian Biggers
    • Sally Knox
    • Jeff Lamont

    Breast Oncology 04 February 2009 Pages: 969 - 971

28. Men With Breast Cancer Have Same Disease-Specific and Event-Free Survival as Women

    • Frédéric Marchal
    • Magalie Salou
    • Emmanuel Desandes

    Breast Oncology 30 January 2009 Pages: 972 - 978

29. A Contemporary, Population-Based Study of Lymphedema Risk Factors in Older Women with Breast Cancer

    • Tina W. F. Yen
    • Xiaolin Fan
    • Ann B. Nattinger

    Breast Oncology 05 February 2009 Pages: 979 - 988

30. Sentinel Node Biopsy in Patients with Previous Breast Aesthetic Surgery

    • Julia Rodriguez Fernandez
    • Stefano Martella
    • Paolo Veronesi

    Breast Oncology 11 February 2009 Pages: 989 - 992

    

31. Hyperthermic Intraperitoneal Chemotherapy After Extensive Cytoreductive Surgery in Patients with Primary Advanced Epithelial Ovarian Cancer: Interim Analysis of a Phase II Study

    • Myong Cheol Lim
    • Sokbom Kang
    • Sang-Yoon Park

    Gynecologic Oncology 24 January 2009 Pages: 993 - 1000

    

32. Impact of Hospital Volume on Surgical Outcome for Head and Neck Cancer

    • Michael C. Cheung
    • Leonidas G. Koniaris
    • Rabih M. Salloum

    Head and Neck Oncology 04 November 2008 Pages: 1001 - 1009

    

33. Neurogenic Tumors of the Pelvis: Clinicopathologic Features and Surgical Outcomes Using a Multidisciplinary Team

    • Eric J. Dozois
    • Jarrod C. H. Wall
    • David W. Larson

    Neuro-Oncology 05 February 2009 Pages: 1010 - 1016

    

34. Surgical Factors Influence the Outcome After Ivor-Lewis Esophagectomy with Intrathoracic Anastomosis for Adenocarcinoma of the Esophagogastric Junction: A Consecutive Series of 240 Patients at an Experienced Center

    • Katja Ott
    • Franz G. Bader
    • J. Ruediger Siewert

    ORIGINAL ARTICLE-THORACIC ONCOLOGY 03 February 2009 Pages: 1017 - 1025

    

35. Pulmonary Resection for Colorectal Cancer Metastases: Duration Between Cancer Onset and Lung Metastasis as an Important Prognostic Factor

    • Been-Ren Lin
    • Tung-Chen Chang
    • Jin-Tung Liang

    Thoracic Oncology 29 January 2009 Pages: 1026 - 1032

    

36. Lung Cancer as a Second Primary Malignancy: Increasing Prevalence and Its Influence on Survival

    • Silvia Quadrelli
    • Gustavo Lyons
    • Carlos Silva

    Thoracic Oncology Open access 04 February 2009 Pages: 1033 - 1038

    

37. Partial Upper Sternotomy for Anterosuperior Mediastinal Surgery: An Institutional Experience

    • Subroto Paul
    • Paul C. Lee
    • Jeffrey L. Port

    Thoracic Oncology 05 February 2009 Pages: 1039 - 1042

38. Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis

    • T. M. Earl
    • I. B. Nicoud
    • R. S. Chari

    Laboratory and Translational Research 23 January 2009 Pages: 1043 - 1050

    

39. Positive Regulation of Human Telomerase Reverse Transcriptase Gene Expression and Telomerase Activity by DNA Methylation in Pancreatic Cancer

    • Alpana Kumari
    • Radhika Srinivasan
    • Jai Dev Wig

    Laboratory and Translational Research 05 February 2009 Pages: 1051 - 1059

    

40. A Career in Surgical Oncology: Not Finding Meaning, Balance, and Personal Satisfaction

    • Muhammad A. Hena

    Healthcare Policy and Outcomes 24 January 2009 Pages: 1060 - 1061

41. In Reply: More on Burnout and Surgical Oncology

    • Tait Shanafelt

    Healthcare Policy and Outcomes 13 November 2008 Pages: 1062 - 1062

42. Neoadjuvant Chemotherapy for Breast Cancer: Does Pretreatment Axillary Nodal Staging Improve Decision Making?

    • Charalabos Batsis
    • Dimosthenis Ziogas
    • Michael Fatouros

    Breast Oncology 10 February 2009 Pages: 1063 - 1064

43. Timing of Axillary Staging

    • M. Catherine Lee
    • Kandice E. Kilbride

    Breast Oncology 06 February 2009 Pages: 1065 - 1065

44. In Reply: In Favor of Axillary Lymph Node Dissection: Need for a Pragmatic View

    • Srila Samphao
    • Oleg Eremin

    Breast Oncology 24 January 2009 Pages: 1066 - 1067

45. Challenges in Developing Robust Genetic Markers and Targets to Predict and Prevent Distant and Peritoneal Recurrence in Gastric Cancer

    • D. Ziogas
    • D. H. Roukos

    Gastrointestinal Oncology 29 January 2009 Pages: 1068 - 1069

46. Important Matters to Identify Robust Markers for Metastasis and Recurrence in Solid Cancer

    • Koshi Mimori
    • Masaaki Iwatsuki
    • Masaki Mori

    Gastrointestinal Oncology 24 January 2009 Pages: 1070 - 1071

47. Laparoscopic Peritoneal Cytology: Can it Affect Decision-Making for Neoadjuvant Treatment of Gastric Cancer?

    • T. Liakakos
    • A. Polychronidis
    • A. Macheras

    Gastrointestinal Oncology 28 January 2009 Pages: 1072 - 1073

48. Is There a Role for Surgery in Recurrent Gastric Cancer

    • C. Bali
    • D. Ziogas
    • M. Fatouros

    Gastrointestinal Oncology 29 January 2009 Pages: 1074 - 1075

49. Gastroesophageal Cancer Research, Study Design, and Continuing Dialogue

    • Brian Badgwell
    • Paul Mansfield

    Gastrointestinal Oncology 23 January 2009 Pages: 1076 - 1076

50. Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

    • Roberto Persiani
    • Stefano Rausei
    • Domenico D’Ugo

    Gastrointestinal Oncology 24 January 2009 Pages: 1077 - 1079